# HepaRAS Trial: Changes in Hepatectomy Risk Assessment When Using Mebrofenin HIDA

> **NCT05280990** · NA · WITHDRAWN · sponsor: **Boris Gala Lopez**

## Conditions studied

- Liver Failure as A Complication of Care
- 30-day Mortality

## Interventions

- **DIAGNOSTIC_TEST:** mHBS
- **DIAGNOSTIC_TEST:** CT/MRI volumetry

## Key facts

- **NCT ID:** NCT05280990
- **Lead sponsor:** Boris Gala Lopez
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2023-01-15
- **Primary completion:** 2025-02-28
- **Final completion:** 2025-07-30
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Technical requirements not met.
- **Last updated:** 2024-02-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05280990

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05280990, "HepaRAS Trial: Changes in Hepatectomy Risk Assessment When Using Mebrofenin HIDA". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05280990. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*